Efficacy of a topical herbal and mineral formulation (Dynamiclear) for the treatment of herpes simplex labialis in the community setting: study protocol for a randomised, double-blind placebo-controlled trial.
Michael ArmourAlex SempriniCarolyn EeLois MacCullaghNick ShorttPublished in: BMJ open (2020)
Australian ethics approval from Western Sydney University Human Research Ethics Committee, ref: H12776. New Zealand Ethics approval from The Health and Disability Ethics Committees (HDEC) ref: 18/CEN/151. Results will be published in a peer-reviewed academic journal, presented at academic meetings and reported to participants TRIAL REGISTRATION NUMBERS: Australia and New Zealand Clinical Trials Registry (ACTRN12618000890235); Universal Trial Number (UTN) (U1111-1233-2426).
Keyphrases
- clinical trial
- public health
- double blind
- phase iii
- study protocol
- phase ii
- big data
- placebo controlled
- open label
- healthcare
- global health
- mental health
- endothelial cells
- randomized controlled trial
- machine learning
- multiple sclerosis
- systematic review
- south africa
- health information
- artificial intelligence
- drug administration
- combination therapy
- social media
- climate change
- risk assessment
- replacement therapy